Application Nr Approved Date Route Status External Links
ANDA203820 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Repaglinide Tablets Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. Limitation Of Use: Repaglinide Tablets Should Not Be Used In Patients With Type 1 Diabetes Mellitus Or For The Treatment Of Diabetic Ketoacidosis. Repaglinide Tablets Are A Glinide Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. (1) Limitation Of Use : Not For Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Repaglinide REPAGLINIDE ZINC3798537

Comments